巨子 ICON - 財經股票資訊及專家分析
搜尋 股票

Edesa Biotech

EDSA
最少15分鐘延遲,股票資訊由第三方資訊供應商提供
・Edesa Biotech - 延遲價格・最後更新於 23/01 21:59
最高位
--
最低位
--
開市價
--
前收市價
4.300
成交量(千)
--
成交額(百萬)
--
買入
--
賣出
--
每手股數
--
市值(百萬)
58.13
市盈率
--
息率
--
差價
--
52週高低
12.000 - 4.150
所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

企業資料

公司名稱
Edesa Biotech
證券代碼
EDSA.US
所屬板塊
Biotechnology
公司業務
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side-effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
發行量
13295403
公司總部
100 Spy Court
公司網址
https://www.edesabiotech.com
公司電郵
investors@edesabiotech.com
公司電話
+1 289 800-9600
暫無內容

關於

Edesa Biotech(EDSA.US)所屬的行業板塊為Biotechnology。
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side-effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
詳細公司背景可參考: https://www.edesabiotech.com